scout
|Videos|June 30, 2017

An Overview of a Study of bb2121 in Multiple Myeloma

Sundar Jagannath, MDDS, professor, Medicine, Hematology, and Medical Oncology, Mount Sinai Hospital, discusses a first in-human multicenter study of bb2121 anti-BCMA CAR T-cell therapy for relapsed/refractory multiple myeloma.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME